Table 2.
Outcome data, randomised patients (N = 44)
| Outcome | Early treatment cd4+ <350 cells/mm3 (N = 21) | Delayed treatment cd4 + < 250 cells/mm3 (N = 23) |
|---|---|---|
| Dead | 2 | 6 |
| Lost to follow-up | 5 | 9 |
| -but known to be alive when project ended | 3 | 4 |
| Started ARV | 14 | 11 |
| Alive with ARV | 12 | 8 |
| Number of days from diagnosis to start of ARV, mean (median) (N = 12 + 8) | 390 (164) | 340 (276) |
| Not started ARV | 7 | 12 |
| Alive without having started ARV | 4 | 3 |
| Number of days from diagnosis to censoring, mean (median) | 857 (808) | 585 (562) |
| Evaluated patients (N = 22) | ||
| Number of patients evaluated (Females + Males) | 14 (8 + 6) | 8 (6 + 2) |
| Age in years, mean (median) | 35 (32) | 39 (40) |
| WHO clinical stage | ||
| stage 1 | 13 | 7 |
| stage 2 | 1 | - |
| stage 4 (aids) | - | 1 |
| cd4+ count, cells/mm3, mean (median) (N = 14 + 7) | 556 (547) | 382 (319) |
| Body mass index (BMI), mean (N = 14 + 8) | 23 · 6 | 22 · 8 |
| Weight in kilos, mean (N = 14 + 8) | 65 · 2 | 62 · 6 |
| Haemoglobin concentration, g/dl, mean (N = 14 + 7) | 12 · 7 | 11 · 2 |